Osteoporosis in steroid taking patients can be explained by all except
## **Core Concept**
The question pertains to the mechanism of osteoporosis development in patients taking steroids (glucocorticoids). Glucocorticoids affect bone metabolism through various pathways, influencing osteoblast and osteoclast activity, calcium absorption, and hormone regulation.
## **Why the Correct Answer is Right**
The correct answer, , involves understanding that glucocorticoids primarily cause osteoporosis by decreasing bone formation through direct inhibition of osteoblasts, enhancing bone resorption indirectly, and affecting calcium and vitamin D metabolism. Glucocorticoids induce osteoblast apoptosis and suppress the synthesis of osteoblast-related genes, leading to decreased bone formation.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Glucocorticoids decrease calcium absorption in the gut, which contributes to osteoporosis. This effect is a valid mechanism.
- **Option B:** Glucocorticoids increase the excretion of calcium in the urine, which can contribute to a negative calcium balance and exacerbate bone loss. This is also a valid mechanism.
- **Option C:** Glucocorticoids can indirectly affect bone health by influencing the hypothalamic-pituitary-gonadal axis, leading to decreased gonadotropin release and subsequently lower sex hormone levels, which are crucial for bone health. This is a valid mechanism.
- **Option D:** This option suggests that glucocorticoids directly increase osteoblast activity. This statement is incorrect as glucocorticoids are known to inhibit osteoblast activity and promote osteoclast activity indirectly.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that glucocorticoid-induced osteoporosis (GIOP) can be prevented or minimized with appropriate prophylaxis, including bisphosphonates, vitamin D and calcium supplementation, and consideration of alternative steroid-sparing agents. Early intervention is crucial.
## **Correct Answer:** . Glucocorticoids directly increase osteoblast activity.